The global nephroblastoma therapeutics industry is on the cusp of significant expansion, with projections indicating a remarkable increase from USD 2.12 billion in 2023 to USD 5.44 billion by 2033. This growth trajectory, representing a compound annual growth rate (CAGR) of 9.88%, underscores the burgeoning demand and advancements in the treatment of nephroblastoma, commonly known …
Category Archives: Healthcare Trends
Cell and Gene Therapy Clinical Trial Industry to Reach USD 119.3 Billion by 2032 with a CAGR of 24.9%
The global Cell and Gene Therapy Clinical Trial Market is witnessing remarkable growth, with sales valued at US$ 10.7 billion in 2021. The market is projected to expand at an impressive CAGR of 24.9% from 2022 to 2032, reaching a valuation of US$ 119.3 billion by 2032. Oncology, the highest revenue-generating segment, is forecasted to …
Physiotherapy Equipment Industry to Reach USD 38,134.8 million by 2033, Growing at a 6.5% CAGR
The global physiotherapy equipment market is set to experience steady growth, with its value projected to rise from US$ 20,367.16 million in 2023 to US$ 38,134.8 million by 2033, reflecting a CAGR of 6.5% during the forecast period. Key factors driving this growth include the increasing prevalence of musculoskeletal disorders, rising adoption of physiotherapy for …
Temperature Monitoring Devices Industry to Reach USD 17.68 Billion by 2034, Growing at a 6.4% CAGR
The global temperature monitoring devices market is poised for steady growth, with its value projected to increase from US$ 10.7 billion in 2024 to US$ 17.68 billion by 2034, reflecting a CAGR of 6.4% over the forecast period. In 2023, the market was valued at US$ 9.50 billion, with a 2.5% year-on-year growth observed in …
Real World Evidence Solutions Industry to Surpass USD 110 Billion by 2032, Growing at a 10% CAGR
The global Real World Evidence (RWE) Solutions market is set for significant growth, rising from US$ 39.2 billion in 2021 to an anticipated US$ 110 billion by 2032, reflecting a robust CAGR of 10% during the forecast period from 2022 to 2032. This marks an acceleration compared to the market’s historical CAGR of 8.6%. The …
Phenylketonuria Therapeutics Industry to Reach USD 2.28 Billion by 2033, Growing at 8.6% CAGR
The global phenylketonuria (PKU) therapeutics market is projected to grow significantly, with its valuation increasing from US$ 1 billion in 2023 to an anticipated US$ 2.28 billion by 2033, reflecting a robust CAGR of 8.6% during the forecast period. This marks a substantial acceleration compared to the 5.2% CAGR recorded during the historical period of …
Chlamydia Diagnostics Industry Poised to Reach USD 3.69 Billion by 2033, Growing at 11% CAGR
The global chlamydia diagnostics market is projected to experience robust growth, with its valuation rising from US$ 1.17 billion in 2022 to an anticipated US$ 3.69 billion by 2033. This growth represents a notable CAGR of 11% during the forecast period from 2023 to 2033, outpacing the 8% CAGR observed between 2018 and 2022. Key …
Genomics Industry to Surge USD 170.5 Billion at 19.8% CAGR, Reaching New Heights by 2032
A newly-released report by Future Market Insights reveals that the global genomics market was valued at US$ 24.3 billion in 2021. The market is set to experience robust growth with a projected CAGR of 19.8% from 2022 to 2032, significantly outpacing its historical growth trajectory. Among the segments, functional genomics is poised to dominate as …
In Vitro Fertilization Industry to Reach USD 1,940.8 Million by 2034, Growing at a 9% CAGR
The global in vitro fertilization (IVF) market is projected to grow significantly, with an anticipated valuation of US$ 819.8 million in 2024. The market is estimated to expand at a CAGR of 9% from 2024 to 2034, reaching US$ 1,940.8 million by 2034. The rising incidence of infertility, driven by factors such as lifestyle changes, …
Remote Patient Monitoring Devices Industry to Reach USD 6.0 Billion by 2034, Growing at a 15.7% CAGR
The global remote patient monitoring devices market is projected to grow significantly from an estimated valuation of USD 1.3 billion in 2024 to USD 6.0 billion by 2034, registering a robust CAGR of 15.7% during the forecast period. The demand for remote patient monitoring devices is being accelerated by several key factors, including: Rising Prevalence …